Six cases of treatment with panitumumab in patients with severe hypersensitivity reactions to cetuximab

Annals of Oncology

Volumn 20, Issue 4, 2009, Pages 798-

  Nielsen, D I ^a   Pfeiffer, P ^b   Jensen, B V ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; CLEMASTINE; EPIDERMAL GROWTH FACTOR RECEPTOR; IRINOTECAN; K RAS PROTEIN; OXALIPLATIN; PANITUMUMAB; PREDNISOLONE;

ADULT; AGED; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; BRONCHOSPASM; CLINICAL ARTICLE; COLORECTAL CANCER; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; DRUG TARGETING; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; HUMAN; HYPERSENSITIVITY REACTION; INFECTION; MALE; METASTASIS; NEUTROPENIA; OVERALL SURVIVAL; PRIORITY JOURNAL; SKIN TOXICITY;

EID: 63549110610     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp040     Document Type: Article

References (5)

1. Cunningham D, Humblet Y, Siena S et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 2004; 351: 337-345.
2. Sørbye H, Glimelius B, Berglund A et al. Multicenter phase II study of Nordic fluorouracil and folinic acid bolus schedule combined with oxaliplatin as first-line treatment of metastatic colorectal cancer. J Clin Oncol 2004; 22: 31-38.
3. Peeters M, Balfour J, Arnold D. Review article: Panitumumab - a fully human anti-EGFR monoclonal antibody for treatment of metastatic colorectal cancer. Alint Pharmacol Ther 2008; 28: 269-281.
4. van Cutsem E, Peeters M, Sienna S et al. Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer. J Clin Oncol 2007; 25: 1658-1754.
5. Cartwright TH, Genther R. Successful administration of panitumumab alone after severe infusion reaction to cetuximab in a patient with metastatic colorectal cancer. Clin Colorectal Cancer 2008; 7: 202-203.